Icare® HOME

tonometer

IOP self-monitoring anywhere, anytime

Icare® HOME tonometer is designed for home use for Glaucoma Patients or suspects, who need regular IOP monitoring by Ophthalmologists recommendation.

Icare® HOME enables IOP monitoring anywhere and anytime, and it is one of the first methods for 24h IOP monitoring outside the clinic. 

The new concept with continuous monitoring provides more information to the Ophthalmologist and comfort for the patient. Also, the clinic efficiency can be improved.

The device is based on a rebound measuring principle that requires no drops, air or specialized skills for its use.

 

Human_no_air_puff_web

KNOWING IS CARING

It’s now possible for healthcare professionals to get platform-free access to their patients’ long term 24/7 IOP-results.

Do you want to know how?

Download REVIEW ON CLINICAL DATA

ON 24-HOUR IOP
MONITORING
AND ICARE HOME

Demonstration videos

Clients who have used this product

Taking normal icare measurements is very straight-forward – I can train novice technicians in 15 minutes. Teaching patients to take their own measurements takes a little longer but is time well spent (around 20 minutes to set-up the device to fit their face and train). The effort is worthwhile because when the patient returns you have a set of IOP measurements for both eyes taken at different times day.

ROBERT HARVEY, CONSULTANT OPHTHALMOLOGIST, VICTORIA, AUSTRALIA

In patients with suspected glaucoma, daily intraocular pressure monitoring is also essential. In a high proportion of these patients, IOP elevations may be missed during regular scheduled examinations. Knowing these pres- sure peaks exist can help control the disease and person- alize and optimize the treatment regimen. Autotonometry is an efficient option for this purpose, as well as being comfortable for the patient.

JOSÉ MARÍA MARTÍNEZ DE LA CASA, MD, PROFESSOR OF OPHTHALMOLOGY UNIVERSITY OF MADRID, SPAIN

In patients with glaucoma, there is a possibility of their eye pressure either fluctuating significantly or being outside the target range (as determined by their doctor). Both these changes are associated with worsening of glaucoma. Monitoring for these changes between office visits can help reassure the doctor and the patient that the therapy is adequate and that the patient is compliant with treatment. If the eye pressure is not stable, then the doctor can recommend additional treatment or tailor the eye drop regimen to stabilize the pressure before permanent loss of tissue or visual field occurs.

SANJAY ASRANI, MD, PROFESSOR OF OPHTHALMOLOGY DUKE EYE CENTER, DURHAM, NC, USA

Where to buy?

Find your local distributor now!

Icare® Products

ICARE-262-STAY-PROTECTED-FLYER-EN-1.0
Stay Protected

A SAFE EYE PRESSURE CHECK

STAY PROTECTED - CHOOSE AN ICARE TONOMETER

Icare’s patented rebound technology is a proven technique for obtaining accurate and rapid IOP measurements from all your patients. With an Icare tonometer a single-use probe is used to measure the eye pressure.

USING AN ICARE TONOMETER IS A SAFE CHOICE FOR YOU AND YOUR PATIENTS

Measuring with an Icare tonometer is free from air puff, anesthesia, drops or other preparation. The Icare tonometers enable hygienic and effortless eye pressure measurement that is barely noticed by the patient, making it suitable for all patients from the very young, to the older generation, even for post-surgical applications.

The Icare tonometers are safe because of the use of a single-use probe.

The Icare tonometers do not create microaerosol formations while a risk of crosscontamination may be present during microaerosol generating procedures like air puff tonometry [1-2].

References

  • Britt JM, Clifton BC, Barnebey HS, Mills RP. Microaerosol formation in noncontact “air-puff” tonometry. Arch Ophthalmol. 1991;109:225–228.
  • Tracy H. T. Lai, Emily W. H. Tang, Sandy K. Y. Chau, Kitty S. C. Fung, Kenneth K. W. Li. Stepping up infection control measures in ophthalmology during the novel coronavirus outbreak: an experience from Hong Kong. Graefe’s Archive for Clinical and Experimental Ophthalmology. 2020; e-published 03 March 2020.